Narayana Health initiates phase II clinical trial of CAR-T
The modified cells called CAR-T cells circulate in patients' body and selectively kill the cancer cells. Unlike chemotherapy, this treatment is highly selective immunotherapy
The modified cells called CAR-T cells circulate in patients' body and selectively kill the cancer cells. Unlike chemotherapy, this treatment is highly selective immunotherapy